SCHEMBL24196743

SCHEMBL24196743

Fc1cccc2ncnc(NCCC3=CCCCC3)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.51
▸ TP53 P04637 4/20 0.51
▸ HTT P42858 4/20 0.51
▸ LMNA P02545 4/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ SMN1; SMN2 Q16637 6/20 0.51
▸ MAPT P10636 5/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ RAB9A P51151 4/20 0.51
▸ GALR3 O60755 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ MAPK1 P28482 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ ALOX15 P16050 3/20 0.41
▸ TSHR P16473 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27371685 0.81 MAPT (0.62) ALDH1A1TP53HTTLMNAL3MBTL1
SCHEMBL24196763 0.73 ALDH1A1 (0.52) ALDH1A1TP53HTTLMNAL3MBTL1
SCHEMBL7510673 0.71 ALDH1A1 (0.47) ALDH1A1TP53HTTLMNAL3MBTL1
SCHEMBL26255153 0.70 ALDH1A1 (0.60) ALDH1A1TP53HTTLMNAL3MBTL1
SCHEMBL26255155 0.70 SMN1; SMN2 (0.56) ALDH1A1TP53HTTLMNAL3MBTL1
SCHEMBL14623890 0.70 CSNK2A2 (0.65) ALDH1A1TP53HTTLMNAL3MBTL1
SCHEMBL8493182 0.70 LDHA (0.44) ALDH1A1HTTLMNASMN1; SMN2RAB9A
SCHEMBL24197153 0.69 ALDH1A1 (0.59) ALDH1A1TP53HTTLMNAL3MBTL1
SCHEMBL24196742 0.69 SMN1; SMN2 (0.55) ALDH1A1TP53HTTLMNAL3MBTL1
SCHEMBL7699390 0.69 ALDH1A1 (0.49) ALDH1A1TP53HTTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279006-A1 NOVEL COMPOUNDS AND METHODS FOR INCREASING KLOTHO GENE EXPRESSION KLOTHO THERAPEUTICS, INC. 2023-09-07 — — US disclosed
US-20230279006-A1 NOVEL COMPOUNDS AND METHODS FOR INCREASING KLOTHO GENE EXPRESSION KLOTHO THERAPEUTICS, INC. 2023-09-07 — — US disclosed
WO-2022011171-A1 NOVEL COMPOUNDS AND METHODS FOR INCREASING KLOTHO GENE EXPRESSION KLOTHO THERAPEUTICS, INC. (US) 2022-01-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230279006-A1 NOVEL COMPOUNDS AND METHODS FOR INCREASING KLOTHO GENE EXPRESSION KLKB1, KLK2, KLK1 ALDH1A1 977/4885TP53 1539/4885HTT 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback